Skip to Main Content

Author Details

James N'Dow
University of Aberdeen
1993
159
42
PMIDPaper TitleJournal TitlePublished Year
37414703Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big Data.Eur Urol2024
37488274From BPH to male LUTS: a 20-year journey of the EAU guidelines.Prostate Cancer Prostatic Dis2024
37980689Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?Int Urol Nephrol2024
35974700Cost-utility analysis of shockwave lithotripsy vs ureteroscopic stone treatment in adults.BJU Int2023
37643846Patient preferences for stress urinary incontinence treatments: a discrete choice experiment.BMJ Open2023
37723589Effectiveness of de-implementation strategies for low-value prescribing in secondary care: a systematic review.Implement Sci Commun2023
36841687Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].Eur Urol2023
36639296Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.Eur Urol2023
36670042Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.Eur Urol Oncol2023
34774465Dissemination of the European Association of Urology Guidelines Through Social Media: Strategy, Results, and Future Developments.Eur Urol Focus2022
37585108Perinatal deaths and low birthweight in an urban health centre in the Gambia: A prospective cohort study.Afr J Reprod Health2022
35577750T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.Eur Urol Focus2022
35353961Single-Incision Mini-Slings for Stress Urinary Incontinence in Women.N Engl J Med2022
36520097Single-incision mini-slings versus standard synthetic mid-urethral slings for surgical treatment of stress urinary incontinence in women: The SIMS RCT.Health Technol Assess2022
36238653A concentric circles view of health data relations facilitates understanding of sociotechnical challenges for learning health systems and the role of federated data networks.Front Big Data2022
35927733Randomised controlled trial comparing the clinical and cost-effectiveness of various washout policies versus no washout policy in preventing catheter associated complications in adults living with long-term catheters: study protocol for the CATHETER II study.Trials2022
36300825Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.Health Technol Assess2022
36163308Shaping the Undergraduate Curriculum in Europe: Consensus Statement from the European School of Urology.Eur Urol2022
36291905A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology.Cancers (Basel)2022
35184906Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium.Eur Urol2022
35301982Shockwave lithotripsy compared with ureteroscopic stone treatment for adults with ureteric stones: the TISU non-inferiority RCT.Health Technol Assess2022
34702647Improving Guideline Adherence in Urology.Eur Urol Focus2022
34785188Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.Eur Urol Oncol2022
33419683European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.Eur Urol2021
33810921Shockwave Lithotripsy Versus Ureteroscopic Treatment as Therapeutic Interventions for Stones of the Ureter (TISU): A Multicentre Randomised Controlled Non-inferiority Trial.Eur Urol2021
34738091Essentials for Standardising the Undergraduate Urology Curriculum in Europe: Outcomes of a Delphi Consensus from the European School of Urology.Eur Urol Open Sci2021
34735807Nuclear medicine theranostics comes of age.Lancet Oncol2021
34407909Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021.Eur Urol2021
34602368The Key Role of Patient Involvement in the Development of Core Outcome Sets in Prostate Cancer.Eur Urol Focus2021
33172773A Systematic Review of the Use of Social Media for Dissemination of Clinical Practice Guidelines.Eur Urol Focus2021
33423943A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research.Eur Urol Oncol2021
33450116What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?BJU Int2021
33129581IMAGINE-IMpact Assessment of Guidelines Implementation and Education: The Next Frontier for Harmonising Urological Practice Across Europe by Improving Adherence to Guidelines.Eur Urol2021
32569563Reprint - Bipolar vs. monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction: A Cochrane review.Can Urol Assoc J2020
34077124Determinants of compliance with the World Health Organisation recommendations for pregnant women in an urban health centre in The Gambia.Afr J Reprod Health2020
31704141Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Urol Oncol2020
31753752EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>â¿ </sup>: Under the Auspices of the EAU-ESMO Guidelines Committees.Eur Urol2020
31992464European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and Management.Eur Urol2020
31836862Sexual function outcomes following interventions for prostate cancer: are contemporary reports on functional outcomes misleading?Int J Impot Res2020
31711931Male Sexual and Reproductive Health-Does the Urologist Have a Role in Addressing Gender Inequality in Life Expectancy?Eur Urol Focus2020
31976821Mobile Telephone Follow-Up to Ascertain Birth Outcomes in The Gambia.Telemed J E Health2020
33228846Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT.Health Technol Assess2020
32947156What are the unmet supportive care needs of men affected by penile cancer? A systematic review of the empirical evidence.Eur J Oncol Nurs2020
32636099Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial).Eur Urol2020
32654801Telemedicine and Smart Working: Recommendations of the European Association of Urology.Eur Urol2020
32446863Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].Eur Urol2020
29154042Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.Eur Urol Focus2019
31740927EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesâ¿ .Ann Oncol2019
31792928Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.Cochrane Database Syst Rev2019
31177994A self-help diet and physical activity intervention with dietetic support for weight management in men treated for prostate cancer: pilot study of the Prostate Cancer Weight Management (PRO-MAN) randomised controlled trial.Br J Nutr2019
  • 1 - 50 of 159

Recommended Authors

Saum Ghodoussipour
Rutgers Cancer Institute of New Jersey
Career Start Year 2016
Number of shared co-authors 0
Zeyad R Schwen
Glickman Urological & Kidney Institute, Cleveland Clinic
Career Start Year 2013
Number of shared co-authors 1
David C Johnson
University of North Carolina School of Medicine
Career Start Year 2012
Number of shared co-authors 1
Aaron A Laviana
Dell Medical School, The University of Texas at Austin
Career Start Year 2010
Number of shared co-authors 0
Michael E Rezaee
The Brady Urological Institute, Johns Hopkins Medicine
Career Start Year 2010
Number of shared co-authors 0
Michael A Liss
University of Texas Health San Antonio
Career Start Year 2008
Number of shared co-authors 1
Shiva M Nair
University of Western Ontario
Career Start Year 2005
Number of shared co-authors 0
Edward Rowe
Bristol Urological Institute, Southmead Hospital
Career Start Year 2004
Number of shared co-authors 5
Young-Suk Lee
Center for RNA Research, Institute for Basic Science
Career Start Year 2004
Number of shared co-authors 0
Bilal Chughtai
New York Presbyterian Hospital-Weill Cornell
Career Start Year 2004
Number of shared co-authors 0
Tim Dudderidge
University Hospital Southampton NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 4
Kerrin Palazzi
Hunter Medical Research Institute
Career Start Year 2002
Number of shared co-authors 1
Nimish Shah
Cambridge University Hospitals NHS Foundation Trust
Career Start Year 2002
Number of shared co-authors 3
John L Gore
University of Washington School of Medicine
Career Start Year 2001
Number of shared co-authors 5
Christopher S Saigal
university of california los angeles Center for Health Sciences
Career Start Year 2001
Number of shared co-authors 0
John K Parsons
university of california san diego Moores Cancer Center
Career Start Year 2001
Number of shared co-authors 4
Erik Mayer
Imperial Clinical Analytics
Career Start Year 2000
Number of shared co-authors 3
Stephanie J Kielb
Northwestern Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Edward M Schaeffer
Northwestern University Feinberg School of Medicine
Career Start Year 1999
Number of shared co-authors 6
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1999
Number of shared co-authors 2
Declan Cahill
Royal Marsden Hospital NHS Trust
Career Start Year 1999
Number of shared co-authors 9
David Robert Siemens
Queen's University
Career Start Year 1996
Number of shared co-authors 3
Omer Acar
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 1
Rizwan Hamid
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 5
Damien Bolton
University of Melbourne
Career Start Year 1988
Number of shared co-authors 5
Roger R Dmochowski
Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 0
William Stuart Reynolds
Vanderbilt University School of Medicine
Career Start Year 1977
Number of shared co-authors 0
Keong Tatt Foo
Rutgers Cancer Institute of New Jersey
Career Start Year 1975
Number of shared co-authors 0
Anthony J Costello
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 9

Collaborators

Alberto Briganti
IRCCS San Raffaele Scientific Institute
Co-authored papers 18
Hendrik Van Poppel
University Hospitals Leuven
Co-authored papers 15
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 9
Giorgio Gandaglia
IRCCS San Raffaele Scientific Institute, Italy Vita-Salute San Raffaele University
Co-authored papers 9
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 8
Nicolas Mottet
Hospitalier Universitaire de Saint-Etienne
Co-authored papers 8
Philip Cornford
Liverpool University Hospitals
Co-authored papers 8
Emma J Smith
University of Guelph
Co-authored papers 8
Monique J Roobol
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Co-authored papers 7
Craig R Ramsay
Health Services Research Unit, University of Aberdeen
Co-authored papers 6
Mieke Van Hemelrijck
School of Cancer and Pharmaceutical Sciences, King's College London
Co-authored papers 5
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 5
Anders Bjartell
Skane University Hospital, Lund University
Co-authored papers 5
Lambertus A Kiemeney
Co-authored papers 5
Arnulf Stenzl
Eberhard Karls University of Tubingen
Co-authored papers 4
Vincent Khoo
The Royal Marsden NHS Foundation Trust and Institute of Cancer Research
Co-authored papers 3
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 3
Alex Asiimwe
Bayer Pharma AG
Co-authored papers 3
Neeraj Agarwal
Co-authored papers 3
Michel Bolla
universite Grenoble-Alpes (UGA)
Co-authored papers 3
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers 3
Inge M van Oort
Radboud University Medical Center
Co-authored papers 3
Vasileios I Sakalis
Hippokrateion General Hospital of Thessaloniki
Co-authored papers 3
Baris Turkbey
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Mark Frydenberg
Monash University
Co-authored papers 3
Ananya Choudhury
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 3
Roderick C N van den Bergh
St. Antonius Hospital
Co-authored papers 3
Nigel Hughes
Janssen Pharmaceutica NV
Co-authored papers 2
Derya Tilki
Universitatsklinikum Hamburg-Eppendorf
Co-authored papers 2
Francesco Pellegrino
Urological Research Institute, IRCCS San Raffaele Hospital
Co-authored papers 2
Release 1.2